Filing summary
Entity and period: This is Marathon Patent Group, Inc.’s unaudited Form 10-Q for the quarter ended March 31, 2015. The filing describes a patent acquisition, licensing, and enforcement business. The request identifies the company as MARA Holdings, Inc.; that name does not match the registrant in this filing and should be verified.
Financial results and position
| Metric | Q1 2015 | Comparable period / balance |
|---|---|---|
| Revenue | $4.09 million | $2.78 million in Q1 2014; up 47% |
| Cost of revenue | $4.33 million | $1.11 million in Q1 2014 |
| Gross result | $(0.23) million; approximately (5.7)% margin | Approximately $1.67 million; 60.1% margin in Q1 2014 |
| Operating loss | $(6.30) million | $(0.28) million in Q1 2014 |
| Net loss / diluted EPS | $(4.78) million / $(0.34) | $(0.28) million / $(0.03) in Q1 2014 |
| Operating cash flow | $(1.15) million | $1.80 million in Q1 2014 |
| Cash at period end | $9.48 million | $5.08 million at December 31, 2014 |
| Notes payable, net carrying value | $25.55 million | $21.96 million at December 31, 2014 |
| Working capital | $(3.22) million | $(14.26) million at December 31, 2014 |
Investing cash outflow was $37,147 and financing cash inflow was $5.57 million. Financing included $19.6 million of net cash proceeds from note issuance and substantial repayments of acquisition and convertible-note debt. Cash increased by $4.40 million during the quarter. The company recorded a $2.49 million income-tax benefit. Patent amortization was $2.60 million, up from $0.45 million in Q1 2014. No dividend was reported.
Material changes and management commentary
- Revenue grew, but cost of revenue rose much faster, turning the gross result negative. Management attributed higher enforcement costs to experts, multiple upcoming trials, and a fixed-fee litigation-counsel engagement.
- Other operating expenses increased 211% to $6.07 million, principally reflecting higher patent amortization after 2014 portfolio acquisitions, compensation, consulting, and professional fees. Management identified $750,328 of non-cash consulting expense as non-recurring.
- Revenue remained concentrated: five licenses accounted for approximately 87% of Q1 2015 revenue, and about 95% came from one-time licenses. Management cautioned that revenue may be highly variable and reliant on a relatively small number of agreements. The company reported 13 license agreements during the quarter.
- The portfolio comprised 360 U.S. and foreign patents, rights to ten additional patents, and 23 patent applications, according to the detailed portfolio note. The filing’s organization note instead says 370 patents and patent rights; verify the portfolio count.
- Management said cash on hand was sufficient for current operations, but acknowledged that changes in operations could require additional capital. No specific revenue or earnings guidance was provided.
Debt, liquidity, risks, and unusual items
- In January 2015, the company issued Fortress-affiliated DBD $15 million of senior secured notes, due July 29, 2018, bearing cash interest at LIBOR plus 9.75%, with 2.75% per annum paid in kind. The debt is secured by a first-priority interest in company assets, subject to stated exceptions, and certain subsidiaries guarantee it.
- Fortress covenants require at least $1 million of unrestricted cash and monetization revenue of at least $15 million for each of four specified fiscal quarters beginning December 31, 2014. The notes also include customary defaults and a contingent revenue stream for the lender after specified monetization-revenue and repayment thresholds.
- Management and the CEO/CFO concluded disclosure controls were ineffective as of March 31, 2015, citing a limited internal audit function. Management was developing remediation procedures but gave no assurance they would be timely or adequate.
- A former vendor’s 2014 Texas lawsuit alleges breach of contract, unjust enrichment, and fraudulent inducement. The company denies the claims and says it will defend itself. A separate former-consultant dispute was settled in March 2015 for 60,000 common shares and a release.
- The filing states “None” under Item 1A Risk Factors, while elsewhere describing material risks including volatile, concentrated licensing revenue, litigation exposure, debt covenants, and possible need for additional capital.
- Subsequent to quarter-end, an April 7, 2015 consulting agreement with a director provided for a $27,000 monthly retainer and a proposed 280,000-share option, subject to shareholder approval and stated vesting conditions.
Key facts for investors to verify
- Confirm the issuer identity: this filing is for Marathon Patent Group, Inc., not MARA Holdings, Inc.
- Reconcile portfolio disclosures of 370 patents and patent rights versus 360 patents plus contract rights to ten patents.
- Review Fortress note terms, collateral, cash-control arrangements, revenue-sharing provisions, and compliance with the minimum-liquidity and monetization-revenue covenants.
- Assess whether concentrated, mostly one-time licensing revenue can cover enforcement costs, interest, and scheduled obligations; confirm the timing and amount of upcoming debt repayments.
- Check the filing’s cash comparisons: MD&A describes $5.08 million as cash at March 31, 2014, while the balance sheet presents that amount at December 31, 2014 and the cash-flow statement reports $5.41 million at March 31, 2014.
- Evaluate remediation of ineffective disclosure controls and the status and potential exposure of the Dominion Harbor litigation.